Regeneron Pharmaceuticals (REGN) stock forecast for 2024

The forecast has been updated: January 24, 2022 6:00


Regeneron Pharmaceuticals stock price online today

Analyst Target Price

704.58

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Regeneron Pharmaceuticals stock stock today? What is the projected target price level for 2024? How much will it cost in 2024? Regeneron Pharmaceuticals stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2024.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $704.58 target price for Regeneron Pharmaceuticals stock stock.

Today 200 Day Moving Average is the support level (586.09 $).

50 Day Moving Average is the resistance level (632.84 $).




REGN Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 713.28 672.84 726.12 7.34 %
Feb 699.80 674.61 728.77 7.43 %
Mar 713.66 695.67 736.14 5.50 %
Apr 764.40 709.36 815.31 12.99 %
May 721.06 673.68 771.03 12.63 %
Jun 676.28 664.11 704.89 5.79 %
Jul 698.80 666.73 736.54 9.48 %
Aug 678.68 634.70 705.55 10.04 %
Sep 703.11 689.19 738.54 6.68 %
Oct 711.33 692.13 738.22 6.24 %
Nov 703.65 684.65 727.72 5.92 %
Dec 678.95 647.79 707.67 8.46 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Regeneron Pharmaceuticals stock.


Regeneron Pharmaceuticals overview

Regeneron Pharmaceuticals Address

777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, US

Market Capitalization

66 827 223 000 $

EBITDA

7 465 800 000

PE Ratio

9.94

PEG Ratio

1.206

Dividend Per Share

None

Dividend Yield

0

EPS

62.53

Quarterly Earnings Growth YOY

0.939

Quarterly Revenue Growth YOY

0.505

Trailing PE

9.94

Forward PE

14.39

EV To Revenue

5.09

EV To EBITDA

8.23

52 Week High

686.62

52 Week Low

441

50 Day Moving Average

632.84

200 Day Moving Average

586.09

Shares Outstanding

105720000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Regeneron Pharmaceuticals stock forecast for this year


Regeneron Pharmaceuticals stock forecast for Jan 2024.
Estimated Average Forecasted Regeneron Pharmaceuticals Price: 713.28. Positive monthly dynamics of the instrument is expected with 7.338% volatility is expected.

Pessimistic forecast: 672.84

Optimistic: 726.12


Regeneron Pharmaceuticals stock forecast for Feb 2024.
Estimated Average Forecasted Regeneron Pharmaceuticals Price: 699.80. Negative monthly dynamics of the instrument is expected with 7.432% volatility is expected.

Pessimistic forecast: 674.61

Optimistic: 728.77


Regeneron Pharmaceuticals stock forecast for Mar 2024.
Estimated Average Forecasted Regeneron Pharmaceuticals Price: 713.66. Positive monthly dynamics of the instrument is expected with 5.497% volatility is expected.

Pessimistic forecast: 695.67

Optimistic: 736.14


Regeneron Pharmaceuticals stock forecast for Apr 2024.
Estimated Average Forecasted Regeneron Pharmaceuticals Price: 764.40. Positive monthly dynamics of the instrument is expected with 12.995% volatility is expected.

Pessimistic forecast: 709.36

Optimistic: 815.31


Regeneron Pharmaceuticals stock forecast for May 2024.
Estimated Average Forecasted Regeneron Pharmaceuticals Price: 721.06. Negative monthly dynamics of the instrument is expected with 12.625% volatility is expected.

Pessimistic forecast: 673.68

Optimistic: 771.03


Regeneron Pharmaceuticals stock forecast for Jun 2024.
Estimated Average Forecasted Regeneron Pharmaceuticals Price: 676.28. Negative monthly dynamics of the instrument is expected with 5.785% volatility is expected.

Pessimistic forecast: 664.11

Optimistic: 704.89


Regeneron Pharmaceuticals stock forecast for Jul 2024.
Estimated Average Forecasted Regeneron Pharmaceuticals Price: 698.80. Positive monthly dynamics of the instrument is expected with 9.478% volatility is expected.

Pessimistic forecast: 666.73

Optimistic: 736.54


Regeneron Pharmaceuticals stock forecast for Aug 2024.
Estimated Average Forecasted Regeneron Pharmaceuticals Price: 678.68. Negative monthly dynamics of the instrument is expected with 10.042% volatility is expected.

Pessimistic forecast: 634.70

Optimistic: 705.55


Regeneron Pharmaceuticals stock forecast for Sep 2024.
Estimated Average Forecasted Regeneron Pharmaceuticals Price: 703.11. Positive monthly dynamics of the instrument is expected with 6.683% volatility is expected.

Pessimistic forecast: 689.19

Optimistic: 738.54


Regeneron Pharmaceuticals stock forecast for Oct 2024.
Estimated Average Forecasted Regeneron Pharmaceuticals Price: 711.33. Positive monthly dynamics of the instrument is expected with 6.244% volatility is expected.

Pessimistic forecast: 692.13

Optimistic: 738.22


Regeneron Pharmaceuticals stock forecast for Nov 2024.
Estimated Average Forecasted Regeneron Pharmaceuticals Price: 703.65. Negative monthly dynamics of the instrument is expected with 5.918% volatility is expected.

Pessimistic forecast: 684.65

Optimistic: 727.72


Regeneron Pharmaceuticals stock forecast for Dec 2024.
Estimated Average Forecasted Regeneron Pharmaceuticals Price: 678.95. Negative monthly dynamics of the instrument is expected with 8.462% volatility is expected.

Pessimistic forecast: 647.79

Optimistic: 707.67



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 123.82 (24.01.2022) -1.60 %
AbbVie Inc.
ABBV 131.98 (21.01.2022) -0.79 %
Aeterna Zentaris Inc.
AEZS 0.3434 (24.01.2022) 4.12 %
Allakos Inc.
ALLK 6.81 (24.01.2022) -0.58 %
Allogene Therapeutics, Inc.
ALLO 11.34 (24.01.2022) -0.18 %
Amgen Inc.
AMGN 226.08 (24.01.2022) -0.72 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 14.66 (24.01.2022) 4.79 %
Aurora Cannabis Inc.
ACB 4.32 (24.01.2022) -3.14 %
Becton Dickinson and Company
BDX 264.63 (21.01.2022) 0.25 %
Biogen Inc.
BIIB 220.52 (21.01.2022) -2.39 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 110.08 (21.01.2022) -5.10 %
BioNTech SE
BNTX 150.98 (24.01.2022) 2.36 %
bluebird bio, Inc.
BLUE 7.71 (24.01.2022) 6.49 %
Boston Scientific Corp.
BSX 44.86 (14.01.2022) 0.65 %
Bristol-Myers Squibb Company
BMY 62.61 (24.01.2022) -1.46 %
Canopy Growth Corp.
CGC 7.4 (24.01.2022) 1.51 %
Castle Biosciences, Inc.
CSTL 35.44 (24.01.2022) 5.48 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 240.42 (24.01.2022) -1.09 %
Emergent BioSolutions Inc.
EBS 46.97 (21.01.2022) 0.97 %
Exelixis, Inc.
EXEL 18.52 (24.01.2022) 6.93 %
G1 Therapeutics, Inc.
GTHX 8.98 (24.01.2022) 2.98 %
Gilead Sciences, Inc.
GILD 68.57 (24.01.2022) 0.09 %
GlaxoSmithKline plc
GSK 44.38 (24.01.2022) -1.60 %
GoodRx Holdings, Inc.
GDRX 24.23 (24.01.2022) 3.06 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 75.34 (24.01.2022) 0.74 %
Inovio Pharmaceuticals, Inc.
INO 3.92 (24.01.2022) 0.00 %
Johnson & Johnson
JNJ 162.97 (24.01.2022) -1.15 %
Medtronic plc.
MDT 104.21 (24.01.2022) -1.32 %
Merck & Co., Inc.
MRK 78.83 (24.01.2022) -1.44 %
Moderna, Inc.
MRNA 157.3 (24.01.2022) -1.73 %
Novartis AG
NVS 85.13 (24.01.2022) -2.18 %
Novavax, Inc.
NVAX 79.47 (24.01.2022) -6.12 %
ObsEva SA
OBSV 1.5 (24.01.2022) -11.24 %
OrganiGram Holdings Inc.
OGI 1.46 (24.01.2022) 1.39 %
Pfizer Inc.
PFE 51.54 (24.01.2022) -2.37 %
Regeneron Pharmaceuticals, Inc.
REGN 621.48 (24.01.2022) 0.01 %
Sanofi
SNY 50.84 (24.01.2022) -0.78 %
Schrodinger, Inc.
SDGR 27.97 (24.01.2022) 3.29 %
Senseonics Holdings, Inc.
SENS 2.38 (24.01.2022) -8.46 %
Sorrento Therapeutics, Inc.
SRNE 3.535 (24.01.2022) -7.10 %
Stryker Corp.
SYK 251.92 (24.01.2022) -1.08 %
Sundial Growers Inc.
SNDL 0.4783 (21.01.2022) -7.74 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.46 (24.01.2022) -0.59 %
Thermo Fisher Scientific Inc.
TMO 575.8 (24.01.2022) -0.78 %
Tilray, Inc.
TLRY 5.84 (24.01.2022) 0.86 %
UnitedHealth Group, Inc.
UNH 462.27 (24.01.2022) 0.24 %
Veeva Systems Inc.
VEEV 227.36 (24.01.2022) 2.38 %
Zomedica Corp.
ZOM 0.3 (24.01.2022) -0.03 %
Zynerba Pharmaceuticals, Inc.
ZYNE 2.5 (24.01.2022) 5.49 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.